Antiestrogen therapies affect tissue homeostasis of the gerbil (Meriones unguiculatus) female prostate and ovaries

Biology of Reproduction

Volumn 79, Issue 4, 2008, Pages 674-685

  Santos, Fernanda C A ^a,c   Custodio, Ana M G ^a   Campos, Silvana G P ^b   Vilamaior, Patricia S L ^c   Góes, Rejane M ^b   Taboga, Sebastião R ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIRP   (Brazil)

Author keywords

Androgens; Estradiol; Female prostate; Female reproductive tract; Letrozole; Morphology; Ovary; Prostate; Tamoxifen

Indexed keywords

ESTRADIOL; LETROZOLE; PROSTATE SPECIFIC ANTIGEN; TAMOXIFEN CITRATE; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMETRY; BODY WEIGHT; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MECHANISM; DYSPLASIA; ENDOCRINE DISEASE; EPITHELIUM CELL; ESTRADIOL BLOOD LEVEL; FEMALE; GERBIL; GLANDULAR HYPERTROPHY; HOMEOSTASIS; HYPERPLASIA; HYPERTROPHY; IMMUNOCYTOCHEMISTRY; KARYOMETRY; MERIONES UNGUICULATUS; MORPHOMETRICS; NONHUMAN; ORGAN WEIGHT; OVARY; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROSTATE LESION; PROSTATIC DYSPLASIA; SEROLOGY; STEREOLOGY; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE; URETHRA;

ANIMALS; BODY WEIGHT; ESTROGEN ANTAGONISTS; FEMALE; GERBILLINAE; GONADAL STEROID HORMONES; HOMEOSTASIS; MALE; ORGAN SIZE; OVARY; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA;

GERBILLINAE; MERIONES UNGUICULATUS;

EID: 53349118123     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.108.068759     Document Type: Article

References (61)

1. Zaviačič M, Whipple B. Update on the female prostate and the phenomenon of female ejaculation. J Sex Res 1993; 30:148-151.
2. Zaviačič M. The Female Prostate: From Vestigial Skene's Parauretral Glands and Ducts to Woman's Functional Prostate, 1st ed. Bratislava, Slovakia: Slovack Academic Press; 1999.
3. Santos FCA, Carvalho HF, Góes RM, Taboga SR. Structure, histochemistry and ultrastructure of the epithelium and stroma in the gerbil (Meriones unguiculatus) female prostate. Tissue Cell 2003; 35:447-457.
4. Custódio AMG, Góes RM, Taboga SR. Acid phosphatase activity in gerbil prostate: comparative study in male and female during postnatal development. Cell Biol Int 2004; 28:335-344.
5. Gross SA, Didio LJA. Comparative morphology of the prostate in adult male and female of Praomys (Mastomys) natalensis studies with electron microscopy. J Submicros Cytol 1987; 19:77-84.
6. Corradi LS, Gpoes RM, Carvalho HF, Taboga SR. Inhibition of 5-aplha-reductase activity induces stromal remodeling and smooth muscle differentiation in adult gerbil ventral prostate. Differentiation 2004; 72:198-208.
7. Zaviačič M, Jakubovská V, Belošovič J, Breza J. Ultrastructure of the normal adult human female prostate gland (Skene's gland). Anat Embriol (Berl) 2000; 201:51-61.
8. Santos FCA, Leite RP, Custódio AMG, Carvalho KP, Monteiro-Leal LH, Santos AB, Góes RM, Carvalho HF, Taboga SR. Testosterone stimulates growth and secretory activity of the adult female prostate of the gerbil (Meriones unguiculatus). Biol Reprod 2006; 75:370-379.
9. Santos FC, Falleiros-Júnior LR, Corradi LS, Vilamaior PS, Taboga SR. Experimental endocrine therapies promote epithelial cytodifferentiation and ciliogenesis in the gerbil female prostate. Cell Tissue Res 2007; 328:617-624.
10. Sloboda J, Zaviačič M, Jakubovský J, Hammar E, Johnsen J. Metastasizing adenocarcinoma of the female prostate (Skene's paraurethral glands): histological and immunohistochemical prostate markers studies and first ultrastructural observation. Pathol Res Pract 1998; 194:129-136.
11. Custodio AM, Santos FC, Campos SG, Vilamaior PS, Góes RM, Taboga SR. Aging effects on the Mongolian gerbil female prostate (Skene's paraurethral glands): structural, ultrastructural, quantitative, and hormonal evaluations. Anat Rec (Hoboken) 2008; 291:463-474.
12. Dodson MK, Cliby WA, Keeney GL, Peterson MF, Podratz KC. Skene's gland adenocarcinoma with increased serum level of prostate-specific antigen. Gynecol Oncol 1994; 55:304-307.
13. Ali SZ, Smilari TF, Gal D, Lovecchio JL, Teichberg S. Primary adenoid cystic carcinoma of Skene's glands. Gynecol Oncol 1995; 57:257-261.
14. Ebisuno S, Miyai M, Nagareda T. Clear cell adenocarcinoma of the female urethra showing positive staining with antibodies to prostate-specific antigen and prostatic acid phosphatase. Urology 1995; 45:682-685.
15. Islam AHMM, Kato H, Hayama M, Kobayashi S, Ota H, Nishizawa O. Adenocarcinoma of the female paraurethral duct showing neuroendocrine differentiation. Urology 2001; 58:1058.
16. Sharifi-Aghdas F, Ghaderian N. Female paraurethral cysts: experience of 25 cases. BJU Int 2004; 93:353-356.
17. Kato H, Kobayashi S, Islam AM, Nishizawa O. Female para-urethral adenocarcinoma: histological and immunohistochemical study. Int J Urol 2005; 12:117-119.
18. McCluggage WG, Ganesan R, Hirschowitz L, Miller K, Rollason TP. Ectopic prostatic tissue in the uterine cervix and vagina: report of a series with a detailed immunohistochemical analysis. Am J Surg Pathol 2006; 30:209-215.
19. Green S, Furr B. Prospects for the treatment of endocrine-responsive tumours. Endocr Relat Cancer 1999; 6:349-371.
20. Miller WR, Dixon JM, Macfarlane L, Cameron D, Anderson TJ. Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen. Eur J Cancer 2003; 39:462-468.
21. Berstein L, Maximov S, Gershfeld E, Meshkova I, Gamajunova V, Tsyrlina E, Larionov A, Kovalevskij A, Vasilyev D. Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects. Obstet Gynecol 2002; 105:161-165.
22. Haynes BP, Dowsett M, Miller WR, Dixon JM, Bhatnagar AS. The pharmacology of letrozole. J Steroid Biochem Mol Biol 2003; 87:35-45.
23. Smith IE. Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy. J Steroid Biochem Mol Biol 2003; 86:289-293.
24. Cabot MC, Giuliano AE, Volner A, Han TY. Tamoxifen retards glycosphingolipid metabolism in human cancer cells. FEBS Lett 1996; 394:129-131.
25. Dixon JM, Jackson J, Renshaw L, Miller WR. Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes. J Steroid Biochem Mol Biol 2003; 86:295-299.
26. Ingle JN, Suman VJ. Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings. J Steroid Biochem Mol Biol 2003; 86:313-319.
27. Block JL, Block NL, Lokeshwar BL. Inhibition of aromatase activity and growth suppression by 4-methoxy-4-androstene-3, 17-dione in an androgen sensitive human prostatic carcinoma cell line. Cancer Lett 1996; 101:143-148.
28. Tobin VA, Canny BJ. The regulation of gonadotropin-releasing hormone-induced calcium signals in male rat gonadotrophs by testosterone is mediated by dihydrotestosterone. Endocrinology 1998; 139:1038-1045.
29. Fitts JM, Klein RM, Powers CA. Comparison of tamoxifen and testosterone propionate in male rats: differential prevention of orchidectomy effects on sex organs, bone mass, growth, and the growth hormone-IGF-I axis. J Androl 2004; 25:523-534.
30. Olsson AY, Lilja H, Lundwall A. Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen. Genomics 2004; 84:147-156.
31. Bancroft JD, Gamble M. Theory and Practice of Histological Techniques, 5th ed. New York: Churchill Livingstone; 2002.
32. Santos FCA, Corradi LS, Leite RP, Góes RM, Taboga SR. A modified method for the selective staining of elastic system fibers in methacrylate tissue sections. Braz J Morphol Sci 2004; 21:135-138.
33. Taboga SR, Vidal BC. Collagen fibers in human prostatic lesions: histochemistry and anisotropies. J Submicrosc Cytol Pathol 2003; 35:11-16.
34. Vilamaior PSL, Taboga SR, Carvalho HF. Modulation of smooth muscle cell function: morphological evidence for a contractile to synthetic transition in the rat ventral prostate. Cell Biol Int 2005; 29:809-816.
35. Weibel ER. Principles and methods for the morphometric study of the lung and other organs. Lab Invest 1978; 12:131-155.
36. Huttunen E, Romppanen T, Helminen HJ. A histoquantitative study on the effects of castration on the rat ventral prostate lobe. J Anat 1981; 132:357-370.
37. Cotta-Pereira G, Rodrigo FG, David-Ferreira JF. The use of tannic acid-glutaraldehyde in the study of elastic related fibers. Stain Technol 1976; 51:7-11.
38. Watson ML. Staining tissue sections of electron microscopy with heavy metals. J Biophys Biochem Cytol 1958; 4:475-478.
39. Venable JH, Coggeshall R. A simplified lead citrate stain for use in electron microscopy. J Cell Biol 1965; 25:407-408.
40. McPherson SJ, Wang H, Jones ME, Pedersen J, Iismaa TP, Wreford N, Simpson ER, Risbridger GP. Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology 2001; 142:2458-2467.
41. Jarred RA, McPherson SJ, Bianco JJ, Couse JF, Korach KS, Risbridger GP. Prostate phenotypes in estrogen-modulated transgenic mice. Trends Endocrinol Metab 2002; 13:163-168.
42. Roselli CE, Resko JA. Cytochrome P450 aromatase (CYP19) in the non-human primate brain: distribution, regulation, and functional significance. J Steroid Biochem Mol Biol 2001; 79:247-253.
43. Kamat A, Hinshelwood MM, Murry BA, Mendelson CR. Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol Metab 2002; 13:122-128.
44. Santen RJ. Inhibition of aromatase: insights from recent studies. Steroids 2003; 68:559-567.
45. Sinha S, Kaseta J, Santner SJ, Demers LM, Bremmer WJ, Santen RJ. Effect of CGS 20267 on ovarian aromatase and gonadotropin levels in the rat. Breast Cancer Res Treat 1998; 48:45-51.
46. Vicent AL, Gary ER, Willian AS. The pathology of the Mongolian gerbil (Meriones unguiculatus): a review. Lab Anim Sci 1979; 29:645-651.
47. Kaburagi YK, Marino MB, Kirdani RY, Greco JP, Karr JP, Sandberg AA. The possibility of aromatization of androgen in human prostate. J Steroid Biochem 1986; 26:739-742.
48. Hiramatsu M, Maehara I, Ozaki M, Harada N, Orikasa S, Sasano H. Aromatase in hyperplasia and carcinoma of the human prostate. Prostate 1997; 31:118-124.
49. Negri-Cesi P, Poletti A, Colciago A, Magni P, Martini P, Motta M. Presence of 5α-reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue. Prostate 1998; 34:283-291.
50. Simpson E, Rubin G, Clyne C, Robertson K, O'Donnell L, Davis S, Jones M. Local estrogen biosyntesis in males and females. Endocr Relat Cancer 1999; 6:131-137.
51. Risbridger GP, Bianco JJ, Ellem SJ, McPherson SJ. Oestrogens and prostate cancer. Endocr Relat Cancer 2003; 10:187-191.
52. Smith MR, Kaufman D, George D, Oh WK, Kazanis M, Manola J, Kantoff PW. Selective aromatase inhibition for patients with androgen-independent prostate carcinoma. Cancer 2002; 95:1864-1868.
53. Howell A, Cuzick J. Vascular effects of aromatase inhibitors: data from clinical trials. J Steroid Biochem Mol Biol 2005; 95:143-149.
54. White INH. The tamoxifen dilemma. Carcinogenesis 1999; 20:1153-1160.
55. Taguchi O. Reproductive tract lesions in male mice treated neonatally with tamoxifen. Biol Reprod 1987; 37:113-116.
56. Zhang H, McElrath T, Tong W, Pollard JW. The molecular basis of tamoxifen induction of mouse uterine epithelial cell proliferation. J Endocrinol 2005; 184:129-140.
57. Singh J, Handelsman DJ. Imprinting by neonatal sex steroids on the structure and function of the mature mouse prostate. Biol Reprod 1999; 61:200-208.
58. Prins GS, Birch L, Habermann H, Chang WY, Tebeau C, Putz O, Bieberich C. Influence of neonatal estrogens on rat prostate development. Reprod Fertil Dev 2001; 13:241-252.
59. Omoto Y, Imamov O, Warner M, Gustafsson JA. Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen. Proc Natl Acad Sci U S A 2005; 102:1484-1489.
60. Risbridger GP, Almahbobi GA, Taylor RA. Early prostate development and its association with late-life prostate disease. Cell Tissue Res 2005; 322:173-181.
61. Härkönen PL, Mäkelä SI. Role of estrogens in development of prostate cancer. J Steroid Biochem Mol Biol 2004; 92:297-305.